Ruth Arnon
Description
Ruth Arnon is an Israeli biochemist and codeveloper of the multiple sclerosis drug Copaxone. She is currently the Paul Ehrlich Professor of ...
Investor Profile
Ruth Arnon has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Grant rounds (top funding stages).
- Majority of deals are located in Israel.
- Strong thematic focus on Financial Services, Management Consulting, Non Profit.
Stage Focus
- Grant (100%)
Country Focus
- Israel (100%)
Industry Focus
- Financial Services
- Management Consulting
- Non Profit
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
